Personally, I think that they are well into the application for approval process, so don't expect any news in this regard in the near future (2-4 weeks).
I think that the next milestone will more than likely be the MIA for Sawston. It could literally come any day.
I would love for us to get some results released from the combo trial, as I know some who have been expecting this for some time. I think they had to wait for the JA to get published before they wanted to talk about the combo trial, as it gives them a solid idea of the future of approval for Mucidencel, which is important as it is the central drug for the combo trial.
I doubt it will happen, but an uplisting overnight (either with or without an R/S, depending on SP) would be nice. Regardless of what Ex says, I have been told by attorneys who specialize in listings that this is absolutely possible.
Further down the line, I expect we will get some MAA and BLA news, as I expect we are well into these processes.
Also, we could see additional journal articles with a more in depth discussion of the stats.
Other than that, I do not think that NWBO will be bought out for some time and I think that management need to let this permeate for a little while before putting ink on any JV or partnership. As the news spread and the SP hopefully moves up on this, they would likely be in a much stronger position later this year or earlier next year.
JMHO
AI
Market Data 
Markets 
